Niagen Bioscience
NAGE | NASDAQ
$2.01
-$0.06 (-2.66%)
At close: Nov 16, 2026, 4:00 PM ET
$1.96
-$0.05 (-2.49%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-2.66%
(1D)Rating
46.5
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #358/1021 (Top 35%)
Key Statistics
Market Data
Market Cap $159.19M
1D Range
1.97 2.07
52W Range
1.97 7.04
Valuation (TTM)
PE 16.75
PB 1.92
EV/EBITDA 13.45
Valuation (NTM)
Forward PE 34.33
Forward PEG -0.24
Price Target $10.00
Cash Flow
FCF Yield 2.9%
SBC Adj. FCF Yield -1.3%
SBC Impact -146.5%
Margins
Gross Margin 63.9%
Operating Margin 2.3%
FCF Margin 3.7%
Growth (CAGR)
Revenue 3Y | 5Y 13.6% |
13.4%
Dil EPS 3Y | 5Y 40.0% |
7575.3%
FCF 3Y | 5Y -7.8% |
203.9%
Returns
ROA 9.4%
ROE 12.6%
ROIC 2.8%
Financial Health
Net Debt
-
Current Ratio 5.93
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It prov...
Sector Healthcare
Industry Biotechnology
Employees 117
IPO Date Jun 24, 2015
Website www.niagenbioscience.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 4, 2026
EPS
-$0.01
Miss -49.93%
YoY:
-120.00% REV
$27.19M
Miss -10.02%
YoY:
-19.99%Next Earnings
Mar 3, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$10.00
Upside
+397.51%
Buy (3)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove NAGE